Analysis claims papers drafted by medical writers downplayed risks of hormone replacement therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fugh-Berman, A. J. PLoS Medicine 7, e1000335 (2010).
Writing Group for the Women's Health Initiative Investigators. J. Am. Med. Assoc. 288, 321-333 (2002).
Related links
Related links
Related links in Nature Research
Wyeth's ghostwriting skeletons yanked from the closet
Related external links
Rights and permissions
About this article
Cite this article
Callaway, E. Questions over ghostwriting in drug industry. Nature (2010). https://doi.org/10.1038/news.2010.453
Published:
DOI: https://doi.org/10.1038/news.2010.453
This article is cited by
-
A new direction for science and values
Synthese (2014)